Evidence map›Paper›PMID 38652060›Full record

Observational studyThe British journal of psychiatry : the journal of mental science2024

The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study.

Emilio Fernandez-Egea, Shanquan Chen, Estela Sangüesa, Patricia Gassó, Marjan Biria, James Plaistow, Isaac Jarratt-Barnham, Nuria Segarra, Sergi Mas, Maria-Pilar Ribate and 5 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in The British journal of psychiatry : the journal of mental science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 3 countries.

Emilio Fernandez-EgeaCambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK; Department of Psychiatry, University of Cambridge, UK; and Behavioural and Clinical Neuroscience Institute, University of Cambridge, UK.ORCID 0000-0003-4128-8955
Shanquan ChenDepartment of Psychiatry and Division of Psychology and Language Sciences, University College London, UK.ORCID 0000-0002-4724-4892
Estela SangüesaFaculty of Health Sciences, Universidad San Jorge, Spain.
Patricia GassóDepartment of Basic Clinical Practice, University of Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
Marjan BiriaBehavioural and Clinical Neuroscience Institute, University of Cambridge, UK; and Department of Psychology, University of Cambridge, UK.
James PlaistowCambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
Isaac Jarratt-BarnhamCambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK; Medical Sciences Division, University of Oxford, UK.
Nuria SegarraCambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
Sergi MasDepartment of Basic Clinical Practice, University of Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.ORCID 0000-0003-3336-6298
Maria-Pilar RibateFaculty of Health Sciences, Universidad San Jorge, Spain.
Cristina B GarcíaFaculty of Health Sciences, Universidad San Jorge, Spain.
Naomi A FinebergHertfordshire Partnership University NHS Foundation Trust, Welwyn Garden City, UK; and School of Life and Medical Sciences, University of Hertfordshire, UK.
Yulia WorbeDepartment of Neurophysiology, Sorbonne Université, France; Department of Neurophysiology, Saint-Antoine Hospital, Paris, France; and Institute du Cerveau et de la Moelle Epinière, Paris, France.
Rudolf N CardinalCambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK; and Department of Psychiatry, University of Cambridge, UK.
Trevor W RobbinsBehavioural and Clinical Neuroscience Institute, University of Cambridge, UK; and Department of Psychology, University of Cambridge, UK.
University of Cambridge · GBUniversidad San Jorge · ESCambridgeshire and Peterborough NHS Foundation Trust · GBCentro de Investigación Biomédica en Red de Salud Mental · ESSorbonne Université · FRUniversity College London · GBUniversity of Hertfordshire · GBUniversity of Oxford · GB

Funding

Medical Research Council MC_PC_17213Medical Research Council MC_PC_19213Medical Research Council MR/W014386/1Medical Research Council MR/W029987/1
6 · The paper itself

Abstract

backgroundA significant proportion of people with clozapine-treated schizophrenia develop 'checking' compulsions, a phenomenon yet to be understood.

aimsTo use habit formation models developed in cognitive neuroscience to investigate the dynamic interplay between psychosis, clozapine dose and obsessive-compulsive symptoms (OCS).

methodUsing the anonymised electronic records of a cohort of clozapine-treated patients, including longitudinal assessments of OCS and psychosis, we performed longitudinal multi-level mediation and multi-level moderation analyses to explore associations of psychosis with obsessiveness and excessive checking. Classic bivariate correlation tests were used to assess clozapine load and checking compulsions. The influence of specific genetic variants was tested in a subsample.

resultsA total of 196 clozapine-treated individuals and 459 face-to-face assessments were included. We found significant OCS to be common (37.9%), with checking being the most prevalent symptom. In mediation models, psychosis severity mediated checking behaviour indirectly by inducing obsessions (

conclusionsWe elucidated different phases of the complex interplay of psychosis and compulsions, which may inform clinicians' therapeutic decisions.

Indexed as

Antipsychotic AgentsClozapinePsychotic DisordersSchizophrenia, Treatment-ResistantAdultCompulsive BehaviorFemaleHumansLongitudinal StudiesMaleMiddle AgedObsessive-Compulsive DisorderSchizophreniaAntipsychotic AgentsClozapineclozapinecompulsionHabit formationserotonintreatment-resistant schizophrenia

Identifiers

PMID38652060
PMCPMC11039551
OpenAlexW4395036427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.